The US Food and Drug Administration has accepted a new drug application by Sanofi-Aventis and Pfizer of the United States for Exubera, a dry powder form of insulin that is inhaled into the lungs prior to eating.
Read More »Rosiglitazone Improves Glucose Uptake In The Heart
Rosiglitazone therapy significantly improved myocardial glucose uptake in type 2 diabetic patients with ischemic coronary artery disease.
Read More »Seniors Look to Doctors For Medicare Drug Info
Physicians are not aware of the details regarding what new things Medicare is covering
Read More »The Real Story on Canola Oil (Can-ugly Oil)
Canola Oil Real or Imagined, Fred Pescatore, MD, MPH, CCN author of The Hampton’s Diet explains how canola oil came about, why it is so popular and why we should avoid it, as he helps us learn about The Science of Fats, Fatty Acids and Edible Oils Can-ugly Oil my …
Read More »Beta-Cell Dysfunction Implicated in Low Birth Weight-Related Diabetes
Findings from a study suggest that primary beta-cell dysfunction plays a key role in the pathogenesis of low birth weight (LBW)-associated type 2 diabetes.
Read More »Preventing Diabetes Hospitalizations Could Save U.S. $2.5 Billion Annually
Hospital costs for patients with multiple stays averaged $23,100 and women with diabetes were two to four times as likely to be hospitalized for cardiovascular disease as women who did not have diabetes.
Read More »Increased Risk for Peripheral Arterial Disease Mortality in Patients With Diabet
Increased Risk for Peripheral Arterial Disease Mortality in Patients With Diabetes Persons with both peripheral arterial disease and diabetes had an adjusted risk of death greater than two-fold that for persons with peripheral arterial disease alone. Patients need to be monitored more often for PAD.
Read More »Diabetes: A Growing Concern in Long-Term Care Facilities
26 percent of nursing home residents have diabetes.
Read More »Exercise Necessary for Losing Abdominal Fat
Study Shows Diabetic Women Can’t Rely on Diet Alone.
Read More »Lifestyle and Metformin Interventions Cost-Effective for Preventing Diabetes
New research indicates that the The Diabetes Prevention Program (DPP) approach is cost-effective, in delaying or preventing the development of Type 2 diabetes, involving lifestyle and metformin interventions.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.